BRIEF published on 08/06/2026 at 08:05, 1 month 18 days ago Pentixapharm publie ses résultats du deuxième trimestre et du premier semestre 2026 et fait progresser son programme de phase 3. Résultats Financiers Procédure Accélérée De La FDA Pentixapharm Pipeline En Oncologie Phase 3 PANDA
BRIEF published on 08/06/2026 at 08:05, 1 month 18 days ago Pentixapharm Reports Q2 and H1 2026 Results and Advances Phase 3 Program Financial Results Oncology Pipeline FDA Fast Track Pentixapharm Phase 3 PANDA
PRESS RELEASE published on 08/06/2026 at 08:00, 1 month 18 days ago Pentixapharm Reports Second Quarter and First Half 2026 Results and Advances Phase 3 Panda Program Pentixapharm Holding AG reports financial results for second quarter and first half of 2026, advancing Phase 3 Panda Program in oncology and cardiovascular sectors Financial Results Oncology Phase 3 Pentixapharm PANDA Program
BRIEF published on 07/31/2026 at 09:05, 1 month 24 days ago Pentixapharm Holding AG Advances with PentixaFor in Phase 3 Capital Raise Phase 3 PentixaFor Radiopharma PANDA Study
BRIEF published on 07/31/2026 at 09:05, 1 month 24 days ago Pentixapharm Holding AG fait progresser le PentixaFor en phase 3 Phase 3 Levée De Capitaux PentixaPour Radiopharma Étude PANDA
PRESS RELEASE published on 07/31/2026 at 09:00, 1 month 24 days ago Original-Research: Pentixapharm Holding AG (von NuWays AG): BUY Research update: Pentixapharm Holding AG positioned for Phase 3 with strong financing secured for PentixaFor diagnostic agent. Potential commercial partnering in 2027. Target price EUR 7.20 Financing Phase 3 Pentixapharm Commercial Partnering Diagnostic Agent
BRIEF published on 07/27/2026 at 20:55, 1 month 27 days ago Pentixapharm Raises EUR 20.4 Million Through Capital Increase Capital Increase FDA Fast Track Pentixapharm [68Ga]Ga-PentixaFor PANDA Phase 3
BRIEF published on 07/27/2026 at 20:55, 1 month 27 days ago Pentixapharm lève 20,4 millions d'euros par augmentation de capital Augmentation De Capital Procédure Accélérée De La FDA Pentixapharm [68Ga]Ga-PentixaPour PANDA Phase 3
PRESS RELEASE published on 07/27/2026 at 20:50, 1 month 27 days ago Pentixapharm Completes Capital Increase – New Shares Placed in Full Pentixapharm completes capital increase, raising EUR 20.4 million for PANDA Phase 3 activities and U.S. expansion after FDA milestones Capital Increase U.S. Expansion Pentixapharm PANDA Phase 3 FDA Milestones
BRIEF published on 07/27/2026 at 20:45, 1 month 27 days ago Pentixapharm lève 20,4 millions d'euros grâce à une offre sursouscrite Augmentation De Capital Développement Clinique Sursouscription Expansion Américaine Plateforme Théranostique
Published on 09/24/2026 at 14:55, 5 hours 44 minutes ago Nextech3D.ai Surpasses $1 Million in New Customer Contract Value, Expands AI Software Portfolio with KATE and Grows Multi-Year Enterprise Agreements
Published on 09/24/2026 at 14:30, 6 hours 9 minutes ago Solitario Resources CEO to Present at the 38th Annual Mining Forum Americas 2026 Conference
Published on 09/24/2026 at 14:00, 6 hours 39 minutes ago Horizon Aircraft to Report First Quarter 2027 Results and Provide a Business Update on October 9, 2026
Published on 09/24/2026 at 14:00, 6 hours 39 minutes ago Reeflex Completes $1.23 Million Goes Order on Schedule Ahead of Vancouver Investor Conference
Published on 09/24/2026 at 19:00, 1 hour 39 minutes ago HIAG provides a first-hand insight into its strategy and the added value it generates at its Capital Market Day
Published on 09/24/2026 at 18:40, 1 hour 58 minutes ago EQS-Adhoc: Brockhaus Technologies AG launches public share buyback offer of approx. €90 million for up to 3,592,000 shares
Published on 09/24/2026 at 18:15, 2 hours 24 minutes ago Epanko Value Engineering Identifies 20% Production Increase
Published on 09/24/2026 at 18:05, 2 hours 34 minutes ago DCK Tools Showcases Expanded Outdoor Power Equipment Lineup at Salonvert 2026
Published on 09/24/2026 at 18:05, 2 hours 34 minutes ago EUHOMY CLOSES IFA 2026 WITH NINE HONORS ACROSS ITS ICE MAKER LINEUP
Published on 09/24/2026 at 18:31, 2 hours 7 minutes ago LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:00, 2 hours 39 minutes ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 2 hours 39 minutes ago GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026
